Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3069% below fair value
$4.01+0.12 (+3.08%)
Close on Nov 12, 2026Market cap $195.19MP/E –Yield –
Nu Skin Enterprises profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Nu Skin Enterprises's profit margin for the twelve months ending Sep 30, 2026 was -17.7%. For fiscal 2025 it was 10.8%, against -8.5% the year before. The highest annual figure on record is 11.5% in fiscal 2013.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10.8% | +19.3 |
| FY2024 | Dec 31, 2024 | -8.5% | −8.9 |
| FY2023 | Dec 31, 2023 | 0.4% | −4.3 |
| FY2022 | Dec 31, 2022 | 4.7% | −0.8 |
| FY2021 | Dec 31, 2021 | 5.5% | −1.9 |
| FY2020 | Dec 31, 2020 | 7.4% | +0.2 |
| FY2019 | Dec 31, 2019 | 7.2% | +2.6 |
| FY2018 | Dec 31, 2018 | 4.5% | −1.1 |
| FY2017 | Dec 31, 2017 | 5.7% | −0.8 |
| FY2016 | Dec 31, 2016 | 6.5% | +0.6 |
| FY2015 | Dec 31, 2015 | 5.9% | −1.4 |
| FY2014 | Dec 31, 2014 | 7.4% | −4.1 |
| FY2013 | Dec 31, 2013 | 11.5% | +1.1 |
| FY2012 | Dec 31, 2012 | 10.4% | +1.5 |
| FY2011 | Dec 31, 2011 | 8.9% | +0.1 |
| FY2010 | Dec 31, 2010 | 8.9% | +2.1 |
| FY2009 | Dec 31, 2009 | 6.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -0.2% | −4.9 |
| Q2 FY2026 | Jun 30, 2026 | -78.0% | −83.5 |
| Q1 FY2026 | Mar 31, 2026 | 0.6% | −28.9 |
| Q4 FY2025 | Dec 31, 2025 | 3.9% | +12.0 |
| Q3 FY2025 | Sep 30, 2025 | 4.7% | +2.8 |
| Q2 FY2025 | Jun 30, 2025 | 5.5% | +32.4 |
| Q1 FY2025 | Mar 31, 2025 | 29.5% | +29.6 |
| Q4 FY2024 | Dec 31, 2024 | -8.1% | −9.6 |
| Q3 FY2024 | Sep 30, 2024 | 1.9% | +9.3 |
| Q2 FY2024 | Jun 30, 2024 | -26.9% | −32.3 |
| Q1 FY2024 | Mar 31, 2024 | -0.1% | −2.5 |
| Q4 FY2023 | Dec 31, 2023 | 1.5% | −9.5 |
| Q3 FY2023 | Sep 30, 2023 | -7.4% | −2.7 |
| Q2 FY2023 | Jun 30, 2023 | 5.4% | −0.7 |
| Q1 FY2023 | Mar 31, 2023 | 2.4% | −4.0 |
| Q4 FY2022 | Dec 31, 2022 | 11.0% | +12.3 |
| Q3 FY2022 | Sep 30, 2022 | -4.7% | −12.5 |
| Q2 FY2022 | Jun 30, 2022 | 6.1% | −2.3 |
| Q1 FY2022 | Mar 31, 2022 | 6.4% | −0.6 |
| Q4 FY2021 | Dec 31, 2021 | -1.4% | −11.2 |
| Q3 FY2021 | Sep 30, 2021 | 7.8% | −0.2 |
| Q2 FY2021 | Jun 30, 2021 | 8.4% | +1.6 |
| Q1 FY2021 | Mar 31, 2021 | 7.0% | +3.2 |
| Q4 FY2020 | Dec 31, 2020 | 9.8% | +2.9 |
| Q3 FY2020 | Sep 30, 2020 | 8.0% | +0.5 |
| Q2 FY2020 | Jun 30, 2020 | 6.8% | −0.6 |
| Q1 FY2020 | Mar 31, 2020 | 3.8% | −3.1 |
| Q4 FY2019 | Dec 31, 2019 | 6.9% | +9.5 |
| Q3 FY2019 | Sep 30, 2019 | 7.5% | −0.4 |
| Q2 FY2019 | Jun 30, 2019 | 7.4% | +0.2 |
| Q1 FY2019 | Mar 31, 2019 | 6.9% | +1.1 |
| Q4 FY2018 | Dec 31, 2018 | -2.6% | −5.3 |
| Q3 FY2018 | Sep 30, 2018 | 7.9% | +0.5 |
| Q2 FY2018 | Jun 30, 2018 | 7.2% | −0.4 |
| Q1 FY2018 | Mar 31, 2018 | 5.8% | +0.3 |
| Q4 FY2017 | Dec 31, 2017 | 2.7% | −4.4 |
| Q3 FY2017 | Sep 30, 2017 | 7.4% | – |
| Q2 FY2017 | Jun 30, 2017 | 7.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 5.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 7.2% | – |
See a number that looks wrong?